|
Market Closed -
Swiss Exchange
16:31:17 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 115.10 CHF | -0.79% |
|
+2.73% | +5.02% |
| 09-18 | Novartis' Cosentyx Gets EU Medicines Agency Panel Recommendation for Polymyalgia Rheumatica | MT |
| 09-18 | Novartis Receives Positive Chmp Opinion for Cosentyx in Polymyalgia Rheumatica | CI |
| Market Cap | 266B 232B 219B 199B 372B 25,496B 374B 2,621B 1,011B 12,962B 998B 976B 41,708B | P/E 2026 * |
19.7x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 297B 259B 245B 222B 416B 28,526B 418B 2,932B 1,131B 14,503B 1,117B 1,092B 46,665B | EV / Sales 2026 * |
5.15x | EV / Sales 2027 * | 4.78x |
| Free-Float |
91.66% | Yield 2026 * |
3.15% | Yield 2027 * | 3.28% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
CBOE
| 0QLR | Real-time | |
|
London S.E.
| 0QLR | Delayed | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
Boerse Muenchen
| NOT | Real-time | |
|
Xetra
| NOT | End-of-day quote | |
|
Xetra
| NOT | Delayed | |
|
OTC Markets
| NVSEF | Delayed | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| NOT | Delayed | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | -0.79% | ||
| 1 week | +2.73% | ||
| Current month | -6.62% | ||
| 1 month | -8.33% | ||
| 3 months | -2.49% | ||
| 6 months | -3.68% | ||
| Current year | +5.02% |
| 1 week | 112.46 |  | 116.98 |
| 1 month | 110.3 | | 132.68 |
| Current year | 107.68 | | 132.68 |
| 1 year | 96.8 | | 132.68 |
| 3 years | 81.1 | | 132.68 |
| 5 years | 72.84 | | 132.68 |
| 10 years | 65.09 | | 132.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 31/01/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 15/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 13/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 31/12/2014 |
| Director/Board Member | 69 | 31/12/2015 | |
Ton Büchner
BRD | Director/Board Member | 61 | 31/12/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/05/26 | Sell | -5,200 | 0.0003% | |||
| 04/05/26 | Sell | 6,800 | 0.0003% | |||
| 17/02/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | +2.73% | +19.03% | +25.08% | 268B | |
| +0.04% | +3.34% | +51.12% | +101.82% | 1,027B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 467B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 350B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 257B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 205B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 190B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 187B | |
| +0.07% | -0.22% | +14.53% | -17.78% | 158B | |
| Average | +0.26% | +2.64% | +24.98% | +39.00% | 375.96B | |
| Weighted average by Cap. | +0.25% | +2.87% | +34.31% | +58.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.74B 50.35B 47.54B 43.17B 80.89B 5,541B 81.22B 569B 220B 2,817B 217B 212B 9,064B | 61.4B 53.54B 50.56B 45.91B 86.01B 5,892B 86.37B 606B 234B 2,995B 231B 226B 9,638B |
| Net income | 14.25B 12.42B 11.73B 10.65B 19.96B 1,367B 20.04B 141B 54.23B 695B 53.52B 52.33B 2,237B | 15.76B 13.75B 12.98B 11.79B 22.08B 1,513B 22.17B 155B 60B 769B 59.22B 57.9B 2,474B |
| Net Debt | 31.58B 27.54B 26B 23.61B 44.24B 3,030B 44.42B 311B 120B 1,541B 119B 116B 4,957B | 27.89B 24.32B 22.96B 20.85B 39.06B 2,676B 39.23B 275B 106B 1,360B 105B 102B 4,377B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | CHF 115.10 | -0.79% | 8,399,187 |
| 17/09/26 | CHF 116.02 | +1.52% | 2,407,734 |
| 16/09/26 | CHF 114.28 | +0.39% | 4,101,101 |
| 15/09/26 | CHF 113.84 | -0.07% | 3,954,861 |
| 14/09/26 | CHF 113.92 | +1.68% | 3,025,084 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
